Basit öğe kaydını göster

dc.contributor.authorKarter, Yesari
dc.contributor.authorÇURGUNLU, Aslı
dc.contributor.authorERTÜRK, Nurten
dc.contributor.authorAydin, Seval
dc.contributor.authorKUTLU, Akif Emre
dc.contributor.authorÖZTÜRK, E
dc.contributor.authorERDİNE, S
dc.contributor.authorUzun, Hafize
dc.contributor.authorSimsek, Gönül
dc.contributor.authorVehid, Suphi
dc.date.accessioned2021-03-05T08:59:43Z
dc.date.available2021-03-05T08:59:43Z
dc.date.issued2005
dc.identifier.citationÇURGUNLU A., Karter Y., Uzun H., Aydin S., ERTÜRK N., Vehid S., Simsek G., KUTLU A. E. , ÖZTÜRK E., ERDİNE S., "Hyperhomocysteinemia - An additional risk factor in white coat hypertension", INTERNATIONAL HEART JOURNAL, cilt.46, ss.245-254, 2005
dc.identifier.issn1349-2365
dc.identifier.otherav_9bb56626-1793-4579-be37-5517c12dfbfe
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/104679
dc.identifier.urihttps://doi.org/10.1536/ihj.46.245
dc.description.abstractThe association between homocysteine and Sustained hypertension (HT) has been Studied. The aim of this study was to assess homocysteine levels in white coat hypertension (WCH) as ail indicator of increased risk in the development of cardiovascular diseases. WCH was defined as clinical hypertension and a daytime ambulatory blood pressure of < 135/85 mmHg. Plasma levels of homocysteine were determined in patients with WCH, hypertension, and normotension (NT). The study group included 100 subjects, 33 with WCH (16 males, 17 females) aged 49.1 +/- 1.9; 35 Sustained hypertensives (17 males,18 females) aged 48.5 +/- 1.7 and 32 normotensive control subjects (15 males, 17 females) aged 48.8 +/- 2.2. The Subjects were matched for age, gender, and body mass index. Patients with a smoking habit, dyslipidemia, or diabetes mellitus were not included in the Study. Homocysteine levels were analyzed by ELISA. Plasma homocysteine levels were significantly higher in the WCH group compared to the controls (12.32 +/- 1.07 versus 5.35 +/- 1.38 mu mol/L; P < 0.001) and the WCH group had significantly lower homocysteine values than the hypertensives (19.03 +/- 0.76 mu mol/L P < 0.001). Total cholesterol and triglycerides were not different among the groups. There were no statistically significant differences in urinary albumin excretion (UAE) or creatinine clearence between the three groups. Hypertensive retinopathy was observed in the WCH group, but Was less Severe and less frequent compared to HTs. LVM1 was greater in the WCH group compared to the NTs. but significantly less than HTs.
dc.language.isoeng
dc.subjectKardiyoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleHyperhomocysteinemia - An additional risk factor in white coat hypertension
dc.typeMakale
dc.relation.journalINTERNATIONAL HEART JOURNAL
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume46
dc.identifier.issue2
dc.identifier.startpage245
dc.identifier.endpage254
dc.contributor.firstauthorID18393


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster